Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease-Reference-Cited by-同舟云学术

Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease

Published:2023-06-02 Issue:8 Volume:35 Page:1741-1752
ISSN:1720-8319
Container-title:Aging Clinical and Experimental Research
language:en
Short-container-title:Aging Clin Exp Res

Author:

de Oliveira Fabricio Ferreira^ORCID,Miraldo Marjorie Câmara^ORCID,de Castro-Neto Eduardo Ferreira^ORCID,de Almeida Sandro Soares^ORCID,Matas Sandro Luiz de Andrade^ORCID,Bertolucci Paulo Henrique Ferreira^ORCID,Naffah-Mazzacoratti Maria da Graça^ORCID

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Aging

Link

https://link.springer.com/content/pdf/10.1007/s40520-023-02452-5.pdf

Reference43 articles.

1. Silverberg N, Elliott C, Ryan L et al (2018) NIA commentary on the NIA-AA research framework: towards a biological definition of Alzheimer’s disease. Alzheimers Dement 14:576–578

2. Paraskevas GP, Bougea A, Constantinides VC et al (2019) In vivo prevalence of Alzheimer biomarkers in dementia with Lewy bodies. Dement Geriatr Cogn Disord 47:289–296

3. McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88–100